2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Thyroid Neoplasms
3
Prostatic Neoplasms
3
Lung Neoplasms
3
Uterine Cervical Neoplasms
2
Stomach Neoplasms
2
Sarcoma, Synovial
2
Sarcoma
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Myelodysplastic Syndromes
2
Multiple Myeloma
2
Liposarcoma
2
Leukemia, Myeloid, Acute
2
Carcinoma, Non-Small-Cell Lung
2
Breast Neoplasms
2
Waldenstrom Macroglobulinemia
1
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Uterine Neoplasms
1
Uterine Cervical Dysplasia
1
Urinary Bladder Neoplasms
1
Ureteral Neoplasms
1
Unspecified Adult Solid Tumor, Protocol Specific
1
Tongue Neoplasms
1
Tobacco Use Disorder
1
Thyroid Nodule
1
Thymus Neoplasms
1
Testicular Neoplasms
1
Skin Neoplasms
1
Sarcoma, Kaposi
1
Salivary Gland Neoplasms
1
Interventions
Colposcopy
18
Imiquimod
14
Conization
12
Papillomavirus Vaccines
9
Vaccines
7
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
7
Cryotherapy
7
Biopsy
6
Acetic Acid
6
human papillomavirus vaccine, L1 type 16, 18
5
Vaginal Smears
5
Papanicolaou Test
5
Human Papillomavirus DNA Tests
5
Blood Specimen Collection
5
Watchful Waiting
4
GX-188 vaccine
4
Surveys and Questionnaires
3
Cisplatin
3
VGX-3100
2
Transurethral Resection of Prostate
2
Topotecan
2
Spectrometry, Fluorescence
2
Restraint, Physical
2
Proflavine
2
Polymerase Chain Reaction
2
Paclitaxel
2
Mass Screening
2
Indomethacin
2
Immunohistochemistry
2
Human Papillomavirus Recombinant Vaccine nonavalent
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Uterine Cervical Dysplasia
×
Molecular Diagnostic Techniques
×
Clear all
NCT02328872
2026-04-17
Compass
VCS Foundation
Phase NA
Active not recruiting
76,181 enrolled